| Wed, Nov 25, 2009 | | • | A Big Upgrade for Amylin Pharmaceuticals
at Motley Fool (Wed 3:20pm)
| | Tue, Nov 24, 2009 | | • | VIVUS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Tue, Nov 24)
| | • | 3 Stocks Ready to Roar
at Motley Fool (Tue, Nov 24)
| | Mon, Nov 23, 2009 | | • | The Side Effect of Developing Obesity Drugs
at Motley Fool (Mon, Nov 23)
| | • | Poniard Finds Cash to Keep Lights On: BioBuzz
at TheStreet.com (Mon, Nov 23)
| | • | Cel-Sci Chairman Sells Stock, Despite Sweetheart Loan Deal: BioBuzz
at TheStreet.com (Mon, Nov 23)
| | • | FDA Issues New Obesity Drug Heart Warning: BioBuzz
at TheStreet.com (Mon, Nov 23)
| | Fri, Nov 20, 2009 | | • | Uncertainty Breeds Opportunity in Specialty Pharma Stock Pick From Piper Jaffray Senior Research Analyst
Wall Street Transcript (Fri, Nov 20)
| | • | Trading Review for Vivus Inc. Issued by Beacon Equity
GlobeNewswire (Fri, Nov 20)
| | • | Biotech Stock Mailbag: FDA Playbook
at TheStreet.com (Fri, Nov 20)
| | Thu, Nov 19, 2009 | | • | CTT's Pain Mangement Device Sales to Result in Positive Surprise in 10Q
at Seeking Alpha (Thu, Nov 19)
| | Wed, Nov 18, 2009 | | • | Trading Biotech Breakthroughs
at CNBC (Wed, Nov 18)
| | • | Coventry, BJ's Wholesale, Vivus are big movers
AP (Wed, Nov 18)
| | • | UPDATE - Vivus says erectile dysfunction trial meets goals
at Reuters (Wed, Nov 18)
| | • | Vivus Shares Rise on Erectile Dysfunction Drug Success
at Fox Business (Wed, Nov 18)
| | • | Obesity and ED: Two Big Markets, One Tiny Company
at Minyanville.com (Wed, Nov 18)
| | • | VIVUS Gets a Spark
at Motley Fool (Wed, Nov 18)
| | • | Vivus Viagra!
at CNBC (Wed, Nov 18)
| | • | Vivus shares rise on positive avanafil study data
AP (Wed, Nov 18)
| | • | Vivus reports postive study results for ED drug
at MarketWatch (Wed, Nov 18)
|
Add VVUS News to My Yahoo!:
 
| |
|
0.29% Nasdaq 
Headlines
